Deutsche Bank’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-150,000
| Closed | -$26.3K | – | 3988 |
|
|
2022
Q4 | $26.3K | Hold |
150,000
| – | – | ﹤0.01% | 3693 |
|
|
2022
Q3 | $65K | Hold |
150,000
| – | – | ﹤0.01% | 3484 |
|
|
2022
Q2 | $128K | Buy |
150,000
+123,234
| +460% | +$105K | ﹤0.01% | 3372 |
|
|
2022
Q1 | $147K | Sell |
26,766
-23,748
| -47% | -$130K | ﹤0.01% | 3393 |
|
|
2021
Q4 | $489K | Sell |
50,514
-1,028
| -2% | -$9.95K | ﹤0.01% | 2850 |
|
|
2021
Q3 | $921K | Buy |
51,542
+2,152
| +4% | +$38.5K | ﹤0.01% | 2663 |
|
|
2021
Q2 | $1.21M | Buy |
49,390
+5,030
| +11% | +$123K | ﹤0.01% | 2644 |
|
|
2021
Q1 | $1.18M | Sell |
44,360
-3,242
| -7% | -$85.9K | ﹤0.01% | 2556 |
|
|
2020
Q4 | $361K | Buy |
47,602
+6,380
| +15% | +$48.4K | ﹤0.01% | 3096 |
|
|
2020
Q3 | $206K | Buy |
41,222
+22,546
| +121% | +$113K | ﹤0.01% | 3163 |
|
|
2020
Q2 | $112K | Buy |
18,676
+6,057
| +48% | +$36.3K | ﹤0.01% | 3339 |
|
|
2020
Q1 | $56K | Sell |
12,619
-13,298
| -51% | -$59K | ﹤0.01% | 3426 |
|
|
2019
Q4 | $245K | Buy |
25,917
+8,573
| +49% | +$81K | ﹤0.01% | 3059 |
|
|
2019
Q3 | $135K | Sell |
17,344
-6,163
| -26% | -$48K | ﹤0.01% | 3341 |
|
|
2019
Q2 | $367K | Sell |
23,507
-14,707
| -38% | -$230K | ﹤0.01% | 3428 |
|
|
2019
Q1 | $689K | Buy |
38,214
+29,840
| +356% | +$538K | ﹤0.01% | 3211 |
|
|
2018
Q4 | $133K | Sell |
8,374
-19,190
| -70% | -$305K | ﹤0.01% | 3958 |
|
|
2018
Q3 | $662K | Buy |
+27,564
| New | +$662K | ﹤0.01% | 3559 |
|